Ask Trustburn about Binder Biotechnology
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
Based on reviews on this page. Verify anything important with the company directly.
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Binder Biotechnology
Binder Bio Group (hereinafter referred to as “Binder Bio”, BindeBio) was established in 2015 and Shenzhen Binder Biotechnology Co., Ltd. is the holding company. Binder Biotech has received strong support from the Shenzhen Municipal Government and has established extensive and in-depth cooperation with the Chinese Academy of Sciences and a number of authoritative hospitals across the country. It is a biotechnology group company that focuses on the treatment of cancer with immune cells. Based on the internationally leading CAR-T and TCR-T immune cell technologies, Binder Biotech is committed to the development and marketing of immunotherapy.
- Website
- bindebio.com
- [email protected]